Amit Alfasi, Author at Peregrine

Ribon Therapeutics announced dosing of the first patient

Restore announces successful First-In-Human preliminary results of Its CONTRABAND™ system

BioProtect presented successful outcomes from its phase I/II study

Levation Pharma, Ltd. received an FDA clearance to initiate Phase I/II of LEV102

EndoStream Medical announced they are conducting their first case in the US as part of the company’s Clinical Trial

Nectin Therapeutics announced a mutual clinical trial with Merck

Ribon Therapeutics announced a $25M investment from Pfizer

EndoStream Medical’s Nautilus device for treating patients with brain aneurysm is featured on the cover of the acclaimed INR

ExoProTher

NextVivo